PURPOSE: We evaluated the chemotherapeutic effect of water extract of white cocoa tea (WCTE) against human prostate cancer (PCa) in vitro and in vivo. METHODS: Cell viability and cell cycle distribution were determined by MTT assay and flow cytometry, respectively. Western blotting was performed to determine changes in levels of various proteins. Effect of WCTE was determined in athymic nude mice implanted with PC-3 cells. RESULTS: Treatment with WCTE (100-150 microg/ml) inhibited cell proliferation, which correlated with G2/M phase arrest in PC-3 cells. WCTE treatment to PC-3 cells resulted in (1) induction of WAF1/p21 and KIP1/p27, (2) decrease in cyclins D1, D2 and E, (3) decrease in cyclin-dependent kinase (cdk) 2, 4 and 6, (4) induction of Bax and down-regulation of Bcl-2, (5) decrease in procaspase-3, -8, (6) inhibition of nuclear translocation and phosphorylation of NF-kappaB and activation of IKKalpha, and (7) inhibition of phosphorylation and degradation of IkappaBalpha. Oral administration of WCTE (0.1 and 0.2%, wt/vol) to athymic nude mice resulted in greater than 50% inhibition of tumor growth. There was a decrease in expressions of cyclin D1, Bcl-2 and p-NF-kappaB and an increase in WAF1/p21 and Bax in tumor tissues of mice. CONCLUSION: WCTE can be a useful chemotherapeutic agent against human PCa.
PURPOSE: We evaluated the chemotherapeutic effect of water extract of white cocoa tea (WCTE) against humanprostate cancer (PCa) in vitro and in vivo. METHODS: Cell viability and cell cycle distribution were determined by MTT assay and flow cytometry, respectively. Western blotting was performed to determine changes in levels of various proteins. Effect of WCTE was determined in athymic nude mice implanted with PC-3 cells. RESULTS: Treatment with WCTE (100-150 microg/ml) inhibited cell proliferation, which correlated with G2/M phase arrest in PC-3 cells. WCTE treatment to PC-3 cells resulted in (1) induction of WAF1/p21 and KIP1/p27, (2) decrease in cyclins D1, D2 and E, (3) decrease in cyclin-dependent kinase (cdk) 2, 4 and 6, (4) induction of Bax and down-regulation of Bcl-2, (5) decrease in procaspase-3, -8, (6) inhibition of nuclear translocation and phosphorylation of NF-kappaB and activation of IKKalpha, and (7) inhibition of phosphorylation and degradation of IkappaBalpha. Oral administration of WCTE (0.1 and 0.2%, wt/vol) to athymic nude mice resulted in greater than 50% inhibition of tumor growth. There was a decrease in expressions of cyclin D1, Bcl-2 and p-NF-kappaB and an increase in WAF1/p21 and Bax in tumor tissues of mice. CONCLUSION:WCTE can be a useful chemotherapeutic agent against human PCa.
Authors: S Hayakawa; K Saeki; M Sazuka; Y Suzuki; Y Shoji; T Ohta; K Kaji; A Yuo; M Isemura Journal: Biochem Biophys Res Commun Date: 2001-08-03 Impact factor: 3.575
Authors: Z Y Wang; M T Huang; T Ferraro; C Q Wong; Y R Lou; K Reuhl; M Iatropoulos; C S Yang; A H Conney Journal: Cancer Res Date: 1992-03-01 Impact factor: 12.701
Authors: Xiao Rong Yang; Elaine Wat; Yan Ping Wang; Chun Hay Ko; Chi Man Koon; Wing Sum Siu; Si Gao; David Wing Shing Cheung; Clara Bik San Lau; Chuang Xing Ye; Ping Chung Leung Journal: Evid Based Complement Alternat Med Date: 2013-07-09 Impact factor: 2.629